International Journal of Colorectal Disease

, Volume 33, Issue 12, pp 1763–1772 | Cite as

Predication of post-operative outcome of colectomy in ulcerative colitis patients using Model of End-Stage Liver Disease Score

  • Nan Lan
  • Bo Shen
  • Jianping WangEmail author
Original Article



Model of End-Stage Liver Disease (MELD) score was developed to predict mortality in patients with liver disease. The aim of this study was to investigate the relationship between preoperative MELD score and 30-day surgical outcomes using the American College of Surgeons National Surgical Quality Improvement Program.


Patients with ulcerative colitis (UC) (ICD: 556.X) who underwent colectomy were identified from NSQIP 2005 to 2013. The primary outcomes were bleeding complications, and overall morbidity and mortality.


A total of 7534 UC patients undergoing colectomy were identified. Patients with a higher MELD score had a longer hospital stay; more bleeding; and cardiac, respiratory, renal, thromboembolic, and septic complications as well as mortality. Patients were stratified into 4 groups by MELD score: < 7, 7–11, 12–15, and > 15 and a stratified multivariate analysis was done. Patients with a MELD score 12–15 (odds ratio [OR] 1.9, 95% confidence interval [CI] 1.1–1.3) and MELD > 15 (OR 2.6, 95%CI 1.5–4.7) were at significant risk for bleeding complication. Apart from the MELD score, the presence of ascites (OR 2.5, 95%CI 1.2–5.1) or varices (OR 1.0, 95%CI 1.01–1.03) was also significantly associated with post-operative bleeding complication. MELD 12–15 and MELD > 15 were also found to be risk factors for overall morbidity (OR 5.3, 95%CI 1.8–15.7; OR 10.3, 95%CI 3.6–29.7, respectively) and mortality (OR 3.3, 95%CI 1.3–8.4; OR 5.9, 95%CI 2.4–14.6, respectively).


UC patients with a higher MELD score were associated with a higher post-colectomy morbidity and mortality. MELD score > 11 was an independent indicator for post-operative bleeding, and overall complications and mortality.


Bleeding Liver disease Model for End-Stage Liver Disease Proctocolectomy Ulcerative colitis 


Funding information

This study was financially supported by the National Key Clinical Discipline (China).

Dr. Bo Shen is supported by the Ed and Joey Story Endowed Chair.

Compliance with ethical standards


The American College of Surgeons National Surgical Quality Improvement Program (ACS NSQIP) and the hospitals participating in the program are the source of the data used herein; they have not verified and are not responsible for the statistical validity of the data analysis or the conclusions derived by the study.


  1. 1.
    Navaneethan U, Shen B (2010) Hepatopancreatobiliary manifestations and complications associated with inflammatory bowel disease. Inflamm Bowel Dis 16:1598–1619CrossRefGoogle Scholar
  2. 2.
    Gizard E, Ford AC, Bronowicki JP, Peyrin-Biroulet L (2014) Systematic review: the epidemiology of the hepatobiliary manifestations in patients with inflammatory bowel disease. Aliment Pharmacol Ther 40:3–15CrossRefGoogle Scholar
  3. 3.
    Eade MN (1970) Liver disease in ulcerative colitis. I. Analysis of operative liver biopsy in 138 consecutive patients having colectomy. Ann Intern Med 72:475–487CrossRefGoogle Scholar
  4. 4.
    Gisbert JP, Luna M, González-Lama Y, Pousa ID, Velasco M, Moreno-Otero R, Maté J (2007) Liver injury in inflammatory bowel disease: long-term follow-up study of 786 patients. Inflamm Bowel Dis 13:1106–1114CrossRefGoogle Scholar
  5. 5.
    Meunier K, Mucci S, Quentin V, Azoulay R, Arnaud JP, Hamy A (2008) Colorectal surgery in cirrhotic patients: assessment of operative morbidity and mortality. Dis Colon Rectum 51:1225–1231CrossRefGoogle Scholar
  6. 6.
    Neeff H, Mariaskin D, Spangenberg HC, Hopt UT, Makowiec F (2011) Perioperative mortality after non-hepatic general surgery in patients with liver cirrhosis: an analysis of 138 operations in the 2000s using child and MELD scores. J Gastrointest Surg 15:1–11CrossRefGoogle Scholar
  7. 7.
    Zielsdorf SM, Kubasiak JC, Janssen I, Myers JA, Luu MB (2015) A NSQIP analysis of MELD and perioperative outcomes in general surgery. Am Surg 81:755–759PubMedGoogle Scholar
  8. 8.
    Lange EO, Jensen CC, Melton GB, Madoff RD, Kwaan MR (2015) Relationship between model for end-stage liver disease score and 30 day outcomes for patients undergoing elective colorectal resection. Dis Colon Rectum 58:494–501CrossRefGoogle Scholar
  9. 9.
    Hedrick TL, Swenson BR, Friel CM (2013) Model for end-stage liver disease in predicting postoperative mortality of patients undergoing colorectal surgery. Am Surg 79:347–352PubMedGoogle Scholar
  10. 10.
    Lian L, Menon KV, Shen B et al (2012) Inflammatory bowel disease complicated by primary sclerosing cholangitis and cirrhosis: is restorative proctocolectomy safe? Dis Colon Rectum 55:79–84CrossRefGoogle Scholar
  11. 11.
    Malinchoc M, Kamath PS, Gordon FD, Peine CJ, Rank J, ter Borg PCJ (2000) A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology 31:864–871CrossRefGoogle Scholar
  12. 12.
    Halabi WJ, Jafari MD, Nguyen VQ, Carmichael JC, Mills S, Pigazzi A, Stamos MJ (2013) Blood transfusions in colorectal cancer surgery: incidence, outcomes, and predictive factors: an American College of Surgeons National Surgical Quality Improvement Program analysis. Am J Surg 206:1024–1032CrossRefGoogle Scholar
  13. 13.
    Mathis KL, Benavente-Chenhalls LA, Dozois EJ, Wolff BG, Larson DW (2011) Short- and long-term surgical outcomes in patients undergoing proctocolectomy with ileal pouch-anal anastomosis in the setting of primary sclerosing cholangitis. Dis Colon Rectum 54:787–792CrossRefGoogle Scholar
  14. 14.
    Kartheuser AH, Dozois RR, LaRusso NF et al (1996) Comparison of surgical treatment of ulcerative colitis associated with primary sclerosing cholangitis: ileal pouch-anal anastomosis versus Brooke ileostomy. Mayo Clin Proc 71:748–756CrossRefGoogle Scholar
  15. 15.
    Mathis KL, Dozois EJ, Larson DW, Cima RR, Sarmiento JM, Wolff BG, Heimbach JK, Pemberton JH (2008) Ileal pouch–anal anastomosis and liver transplantation for ulcerative colitis complicated by primary sclerosing cholangitis. Br J Surg 95:882–886CrossRefGoogle Scholar
  16. 16.
    Gorgun E, Remzi FH, Manilich E, Preen M, Shen B, Fazio VW (2005) Surgical outcome in patients with primary sclerosing cholangitis undergoing ileal pouch-anal anastomosis: a case-control study. Surgery 138:631–637CrossRefGoogle Scholar
  17. 17.
    Cullen S, Chapman R (2003) Primary sclerosing cholangitis. Autoimmun Rev 2:305–312CrossRefGoogle Scholar
  18. 18.
    Gustot T, Durand F, Lebrec D, Vincent JL, Moreau R (2009) Severe sepsis in cirrhosis. Hepatology 50:2022–2033CrossRefGoogle Scholar
  19. 19.
    Poritz LS, Koltun WA (2003) Surgical management of ulcerative colitis in the presence of primary sclerosing cholangitis. Dis Colon Rectum 46:173–178CrossRefGoogle Scholar

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Department of Colorectal Surgery and Guangdong Provincial Key Laboratory of Colorectal and Pelvic Floor Diseases, the Sixth Affiliated HospitalSun Yat-Sen UniversityGuangzhouChina
  2. 2.Department of Gastroenterology, Digestive Disease InstituteCleveland ClinicClevelandUSA

Personalised recommendations